CETP inhibitor, Evacetrapib, Purity ≥98%

Synonym: 1186486-62-3; LY2484595; LY-2484595; LY 2484595; 4-[[(5S)-5-[[3,5-Bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid; CETP inhibitor

MDL: MFCD23105886
CAS Number: 1186486-62-3
Compound CID: 49836058

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Evacetrapib, soluble in DMSO and ethanol and insoluble in water, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting CETP. The molecular weight of the compound is 638.65, and its molecular formula is C₃₁H₃₆F₆N₆O₂. It targets the CETP.

Molecular Weight

638.65

Molecular Formula

C₃₁H₃₆F₆N₆O₂

Targets

CETP

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 11 mg/mL (17.22 mM); Water: insoluble; Ethanol: 11 mg/mL (17.22 mM); In vivo: 15% Captisol, 28 mg/mL

Identity

Confirmed by NMR/HPLC/MS.

Applications

Evacetrapib can be used for its potential to reduce cardiovascular events and improve heart health.